Modular Medical, Inc.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $14.7M+14.1% | $12.9M+42.1% | $9.1M+17.2% | $7.7M |
| General and administrative | $4.4M-6.4% | $4.6M-3.5% | $4.8M-33.1% | $7.2M |
| Total operating expenses | $19.0M+8.7% | $17.5M+26.3% | $13.9M-7.0% | $14.9M |
| Loss from operations | -$19.0M-8.7% | -$17.5M-26.3% | -$13.9M+7.0% | -$14.9M |
| Other income | $226K+270.5% | $61K+6000.0% | $1K-99.7% | $369K |
| Loss before income taxes | -$18.8M-7.8% | -$17.5M-25.9% | -$13.9M+25.5% | -$18.6M |
| Provision for income taxes | $2K+0.0% | $2K+0.0% | $2K+25.0% | $2K |
| Net loss | -$18.8M-7.8% | -$17.5M-25.9% | -$13.9M+25.5% | -$18.6M |
| Basic (in Dollars per share) | -$0.51+34.6% | -$0.78+32.2% | -$1.15+58.0% | -$2.74 |
| Diluted (in Dollars per share) | -$0.51+34.6% | -$0.78 | — | — |
| Basic (in Shares) | 37.0M+65.4% | 22.4M+184788.0% | 12K-99.8% | 6.8M |
| Diluted (in Shares) | 37.0M+65.4% | 22.4M | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
No Form 4 transactions on record.
Informational purposes only, not investment advice.